Does Scripts charge a software fee on top of drug cost?

Two pricing structures with the same headline drug rate can cost very differently once the software layer is included. A recurring monthly platform fee is fixed regardless of volume — cheap per vial at high volume, expensive at low volume. A per-transaction or percentage fee scales with spend. A fee folded into the drug rate is invisible but real. To compare Scripts fairly, ask whether there is a separate software, subscription, or account fee; whether it is monthly, per order, or percentage-based; and whether it changes at volume tiers. Then compute total cost of ownership over a representative month, not just per-vial drug cost.

This is also where an attractive exclusive drug rate can mislead. Scripts markets 'elite pricing' and 'unbeatable pricing' — and the portal rate may genuinely be competitive on the drug line. But if that rate sits alongside a separate platform charge, your effective cost per vial is higher than the portal number suggests. The only honest comparison adds the software layer back in and sets the total against an alternative that discloses both components up front.

Fizy Health structures the two layers to be legible before you order: drug cost passes through as resolved per-vial 503A cost on each catalog and cart line, and the platform's economics are a single facilitation fee disclosed separately at payment. There is no hidden software charge folded into the drug rate, so total cost of ownership is the visible drug cost plus the named fee — a number you can compute before checkout, not after.

That makes a like-for-like comparison straightforward. Add any Scripts software or platform fee to its portal drug rate over a representative month, then set that total against the visible per-vial cost plus disclosed facilitation fee for the same SKUs and volume. Comparing total-to-total — not drug-rate-to-drug-rate — is the only way to see which model actually costs less to run.